Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Leukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hodgkin Disease 1Hematologic Diseases 1Anemia, Sickle Cell 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Dexamethasone 4nelarabine 3Calcium Dobesilate 2terameprocol 1ontuxizumab 1mogamulizumab 1isatuximab 1forodesine 1fludarabine phosphate 1fludarabine 1crenigacestat 1cobomarsen 1calaspargase pegol 1brincidofovir 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Sensitivity and Specificity 1Ranitidine 1Oxaliplatin 1Mycophenolic Acid 1Mesna 1Lenalidomide 1HBI-8000 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Fentanyl 1Diphenhydramine 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Bone Marrow Transplantation × Clear all
NCT05170828 2026-02-24

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Ossium Health, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡